California State Teachers Retirement System Precision Biosciences Inc Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $71,672 - $208,162	-62,324 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $17,801 - $46,668	-6,014 Reduced 8.8%	62,324 $192,000
Q4 2021 Feb 15, 2022	BUY	$7.4 - $11.66 $28,445 - $44,821	3,844 Added 5.96%	68,338 $506,000
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $9,923 - $15,296	-1,081 Reduced 1.65%	64,494 $744,000
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $36,549 - $56,703	-4,529 Reduced 6.46%	65,575 $821,000
Q1 2021 May 18, 2021	BUY	$8.57 - $15.79 $214 - $394	25 Added 0.04%	70,104 $726,000
Q3 2020 Nov 17, 2020	BUY	$4.65 - $8.73 $5,714 - $10,729	1,229 Added 1.79%	70,079 $432,000
Q2 2020 Aug 17, 2020	BUY	$4.66 - $8.7 $62,155 - $116,040	13,338 Added 24.03%	68,850 $574,000
Q1 2020 May 13, 2020	BUY	$5.05 - $15.01 $3,232 - $9,606	640 Added 1.17%	55,512 $335,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $256,541 - $798,038	40,592 Added 284.26%	54,872 $762,000
Q3 2019 Nov 15, 2019	BUY	$8.03 - $14.82 $1,365 - $2,519	170 Added 1.2%	14,280 $120,000
Q2 2019 Aug 14, 2019	BUY	$11.88 - $16.94 $167,626 - $239,023	14,110 New	14,110 $187,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$8.54 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$4.61 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$2.97 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.71 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$1.18 Million
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account